Biomarkers for the diagnosis of thyroid cancer.

Abstract excerpt

Thyroid tumor contributes 1% of the total tumor but 90% of the endocrine related tumors. Majority of the thyroid cancers are being diagnosed by Fine needle aspiration cytology (FNAC) and histology. Although histology is considered as gold standard, it has some limitations, like variants of papillary and follicular cancer creates confusion among pathologists, where the morphological features are indistinguishable....

Topics

Join the communities discussing this publication.

• Biomarkers, Tumor
• EGFR gene
• GAL gene
• Gene Rearrangement
• Immunohistochemistry